JFB welcomes proposals for special issues that highlight emerging priorities in fertility biomarker research and care. Special issues bring focused attention to fast moving topics and support collaborative research communities.

• Working title and thematic focus
• Rationale and relevance to fertility biomarkers
• Proposed guest editors and affiliations
• Target audience and expected contribution
• Preliminary list of potential contributors
• Timeline for submissions and reviews

• Define scope and thematic boundaries
• Recommend reviewers and manage peer review
• Ensure ethical compliance and reporting quality
• Provide an editorial summary upon completion

The JFB editorial office supports special issue planning, reviewer coordination, and production workflows. Send proposals or questions to [email protected].

• Ovarian reserve biomarkers and reproductive aging
• Male factor biomarkers and semen analytics
• Endometrial receptivity and implantation markers
• Embryo selection, morphokinetics, and noninvasive testing
• Multi omics and AI driven fertility prediction
• Fertility preservation and oncofertility biomarkers
• Define the fertility biomarker research gap the special issue addresses.
• Provide a rationale for guest editor expertise and topic coverage.
• Specify anticipated article types and approximate submission volume.
• Outline peer review timelines and editorial decision workflows.
• Describe outreach plans to reproductive medicine and fertility societies.
• Identify data reporting standards required for submissions.
• Clarify whether cross disciplinary submissions are in scope.
• List any planned invited contributions or consortium partners.
• Provide proposed metrics for impact or clinical relevance.
• Describe data harmonization requirements for multicenter submissions.
• Specify expected submission window and targeted publication date.
• Note any regulatory or guideline considerations for topic areas.
• Specify how guest editors will manage conflicts of interest.
• Outline plans for an editorial introduction or synthesis article.
• Describe collaboration with registries or clinical networks.
• Provide criteria for invited versus open submissions.
• Include data reporting checklists for biomarker or omics studies.
• State plans for dissemination to clinical stakeholders.
• Describe plans for consensus statements or clinical guidelines.
• Include expectations for biomarker data reporting consistency.
• Outline strategies to recruit multidisciplinary contributors.
• Provide plans for patient centered outcomes reporting.
• Specify whether imaging or omics datasets will be shared.
• Describe integration with ongoing clinical trials or registries.
• Outline dissemination plans for clinical audiences.
• Describe expectations for systematic review contributions.
• Provide plans for imaging or assay standardization across sites.
• Clarify expectations for genomic or proteomic data deposition.
• Describe strategies for harmonizing outcome definitions.

JFB is committed to rigorous, transparent publishing in fertility biomarker research and reproductive medicine. We emphasize reproducible laboratory methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in biomarker validation, reproductive outcomes, and translational fertility science.